Dr Kazmi qualified from the University of Aberdeen in 1991 with Commendation, he is a member of European group for Blood and Marrow Transplantation (EBMT), International Myeloma Society, Faculty of Medical Leadership and Management and American Society of Haematology (ASH). He has been a consultant since 2001 at Guy’s & St Thomas’ NHS Trust.
He is currently Director of Innovation for Cancer and Surgery at Guy’s & St Thomas’ NHS Trust. He is a venture partner for Advent Life Sciences. He was previously Chief of Cancer services and Clinical Director for Oncology and Haematology.
He led the development of the £160 million Cancer centre built on the Guy’s Hospital Campus. He is a CQC specialist adviser and has supported the work of NICE in providing expert advice to support technology appraisals in myeloma.
Dr Kazmi is seen as an innovator in healthcare. He helped set up the first Trust AI board and appointed the first clinical lead for AI in a UK hospital and implemented digital technologies within the organisation to improve patient experience and safety.
Research Interests / Publications
His clinical interests include Myeloma where he has been the UK Chief Investigator on a number of studies. He has extensive experience in stem cell transplantation and is the EBMT UK lead for transplantation in auto-immune diseases.